Investors

Board of Directors

Florian Schönharting, M.Sc. (Econ)
Florian Schönharting, M.Sc. (Econ)
Chairman
Florian Schönharting is a co-founder of the company and chairman of the board. He possesses over 22 years investment executive experience in both public and private equity funds in biotech and pharmaceuticals, co-founder of NB Capital, prior to this 10 years as key responsible for biopharma public

Chairman
Torsten Goesch, MD, PhD, MBA
Torsten Goesch, MD, PhD, MBA
Board member
Dr. Torsten Goesch is a director of Rosetta Capital, formerly BioScience Managers Limited (BML) which he joined in July 2002. Previously, Dr. Goesch was the founder and Managing Director of TRG Invest (1999-2002), a Munich-based consulting business providing companies in the life science sector

Board member
Grant Hellier Lawrence
Grant Hellier Lawrence
Board member
Grant Hellier Lawrence is currently Managing Director and CFO at Nunc A/S, a Thermo Fish- er Scientific company. He has more than 15 years of financial and IT management experi- ence within global Life Science manufacturing and commercial companies, where he has provided overall leadership and

Board member
Jakob Mosegaard Larsen
Jakob Mosegaard Larsen
Board member
Jakob Mosegaard Larsen is a partner at Copenhagen based law firm, Mazanti-Andersen Korsø Jensen LLP, and serves as a trusted advisor of Danish and international private equity and venture funds. He has several years of experience acting as a legal adviser of biotech and life science companies.

Board member
Dr. Duncan Moore
Dr. Duncan Moore
Board member
Dr. Moore is a partner at East West Capital Partners since May 2008. Previously, Dr Moore was a top ranked pharmaceutical analyst at Morgan Stanley from 1991 to 2008 and was a Managing Director from 1997 to 2008 leading the firm’s global healthcare equity research team.

Board member